WMSA
OREX

Weiss Multi-Strategy Advisers’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-3,273
Closed -$184K – 1280
2013
Q4 		$184K Buy
+3,273
New +$184K ﹤0.01% 914

Other funds holding OREX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Weiss Multi-Strategy Advisers's OREX Position: Q1 2014 in Review

Weiss Multi-Strategy Advisers sold out of Orexigen Therapeutics, Inc. (OREX) in Q1 2014, closing a stake of 3,273 shares — an estimated $184K sold.

Weiss Multi-Strategy Advisers first reported a position in OREX in Q4 2013 and held it in 1 quarter. The position peaked at $184K in Q4 2013. 129 funds tracked by Wall St. Rank hold OREX as of Q1 2014.

  • Weiss Multi-Strategy Advisers reported no remaining Orexigen Therapeutics, Inc. position as of Q1 2014 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 3,273 Orexigen Therapeutics, Inc. shares in Q1 2014, an estimated $184K.
  • Weiss Multi-Strategy Advisers first reported a position in Orexigen Therapeutics, Inc. in Q4 2013 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's Orexigen Therapeutics, Inc. position peaked at $184K in Q4 2013.
  • 129 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q1 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2014, filed 15 May 2014.